Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.70 | N/A |
| PEG Ratio (TTM) | 0.00 | N/A |
| P/S Ratio (TTM) | 0.03 | N/A |
| P/B Ratio (TTM) | 0.06 | N/A |
| P/FCF Ratio (TTM) | 0.48 | N/A |
| Price to 5YR AVG Earnings Ratio | 2.00 | N/A |
| Price to 5YR AVG FCF Ratio | -1.22 | N/A |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.59% | N/A |
| ROE (TTM) | -15.92% | N/A |
| Net Profit Margin (TTM) | -4.62% | N/A |
| ROIC 5YR AVG | 0.59% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 298.06% | 292.22% | 154.77% |
| Revenue | -6.40% | 10.66% | 6.31% |
| Net Income | 292.68% | 313.04% | 173.10% |
| Cash Flow | 262.29% | 218.97% | 126.76% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.16 | N/A |
| Quick Ratio (TTM) | 0.32 | N/A |
| D/E Ratio (TTM) | 0.39 | N/A |
| Interest Coverage (TTM) | 0.13 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 1.84 | N/A |
| LTL to 5YR AVG FCF | -1.29 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.05% | N/A |